159 related articles for article (PubMed ID: 3311345)
1. The prognostic significance of myelonecrosis after induction therapy in acute leukemia.
Cassileth PA; Brooks JS
Cancer; 1987 Nov; 60(10):2363-5. PubMed ID: 3311345
[TBL] [Abstract][Full Text] [Related]
2. Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.
Stone RM; Maguire M; Goldberg MA; Antin JH; Rosenthal DS; Mayer RJ
Blood; 1988 Mar; 71(3):690-6. PubMed ID: 3422828
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of blood and marrow findings in acute myelogenous leukemia in remission. A Southeastern Cancer Study Group report.
Vogler WR; Raney MR
Cancer; 1988 Jun; 61(12):2481-6. PubMed ID: 3163256
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous relapse in a child with acute mixed leukemia.
Barbara A; Besenzon L; Busca A; del Prever AB; Miniero R; Madon E; Foà R; Forni M; Saitta M
Pediatr Hematol Oncol; 1993; 10(1):85-8. PubMed ID: 8443056
[No Abstract] [Full Text] [Related]
5. Residual leukemic cell counts in the bone marrow at the end point of intensive induction therapy may be a prognostic factor for acute myeloblastic leukemia in adults.
Fujisawa S; Maruta A; Motomura S; Fukawa H; Kanamori H; Ogawa K; Matsuzaki M; Miyashita H; Harano H; Murata T; Sakai R; Mohri H; Kodama F; Okubo T
Leuk Lymphoma; 1998 Mar; 29(1-2):161-70. PubMed ID: 9638985
[TBL] [Abstract][Full Text] [Related]
6. Myelonecrosis in acute leukemia.
Prajapati NC; Singh T; Gautam P; Dubey AP; Choudhury P; Puri RK
Indian Pediatr; 1994 Jan; 31(1):60-4. PubMed ID: 7883324
[No Abstract] [Full Text] [Related]
7. Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.
Lee SH; Abebe L; Paietta E; Einzig A; Wiernik PH
Am J Hematol; 2009 Jul; 84(7):455-7. PubMed ID: 19507211
[No Abstract] [Full Text] [Related]
8. All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemia.
Venditti A; Stasi R; Del Poeta G; Buccisano F; Aronica G; Bruno A; Pisani F; Caravita T; Masi M; Tribalto M
Leukemia; 1995 Jul; 9(7):1121-5. PubMed ID: 7630182
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and therapeutic implications of early treatment response assessment in acute myeloid leukemia.
Pullarkat V; Aldoss I
Crit Rev Oncol Hematol; 2015 Jul; 95(1):38-45. PubMed ID: 25624175
[TBL] [Abstract][Full Text] [Related]
10. Rebound peripheral blastosis with subsequent remission during remission induction in a patient with acute promyelocytic leukemia.
Amato R; Kantarjian H; Walters R; Keating M
Cancer; 1988 Feb; 61(4):650-3. PubMed ID: 3422175
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of the therapeutic effect in acute myelogenous leukemia].
Pu Q
Zhonghua Nei Ke Za Zhi; 1993 Oct; 32(10):653-5. PubMed ID: 8156832
[No Abstract] [Full Text] [Related]
12. Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
Dengler R; Plewan A; Münstermann U; Busch R; Eger G; Emmerich B
Clin Cancer Res; 1995 Feb; 1(2):199-205. PubMed ID: 9815974
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia.
Colovic N; Tomin D; Vidovic A; Suvajdzic N; Jankovic G; Palibrk V; Djunic I; Djurasinovic V; Virijevic M
Biomed Pharmacother; 2012 Dec; 66(8):578-82. PubMed ID: 23085253
[TBL] [Abstract][Full Text] [Related]
14. Monitoring the remission induction therapy of acute nonlymphoblastic leukemia by bone marrow cell culture criteria.
Bohinjec J; Zontar D; Kralj J
Leuk Res; 1985; 9(3):369-73. PubMed ID: 3999798
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of colony-forming cells (CFU-c) in adult acute leukemia and their prognostic relevance.
Jehn U; Wachholz K
Leuk Res; 1983; 7(6):761-70. PubMed ID: 6582343
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow necrosis in acute leukemia: Clinical characteristic and outcome.
Badar T; Shetty A; Bueso-Ramos C; Cortes J; Konopleva M; Borthakur G; Pierce S; Huang X; Chen HC; Kadia T; Daver N; Dinardo C; O'Brien S; Garcia-Manero G; Kantarjian H; Ravandi F
Am J Hematol; 2015 Sep; 90(9):769-73. PubMed ID: 26017166
[TBL] [Abstract][Full Text] [Related]
17. [Cancer curable by chemotherapy: acute myelogenous leukemia].
Ohno R; Tanimoto M; Morishita Y; Morishima Y; Saito H; Yokomaku S; Nagai T; Kodera Y; Minami S
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1329-34. PubMed ID: 2730046
[TBL] [Abstract][Full Text] [Related]
18. Identification of early relapsing patients with adult acute nonlymphocytic leukemia by bone marrow biopsy after initial induction chemotherapy.
Cassileth PA; Gerson SL; Bonner H; Neiman RS; Lusk EJ; Hurwitz S
J Clin Oncol; 1984 Feb; 2(2):107-11. PubMed ID: 6699661
[TBL] [Abstract][Full Text] [Related]
19. [Modern strategies in therapy of acute myeloid leukemia (AML) in adulthood. I. Primary treatment of de novo AML].
Jehn U; Dengler R; Petrides PE
Internist (Berl); 1996 Jun; 37(6):661-8. PubMed ID: 8768003
[No Abstract] [Full Text] [Related]
20. Remission from central nervous system involvement in adults with acute leukemia. Effect of intensive therapy and prognostic factors.
Stewart DJ; Smith TL; Keating MJ; Maor M; Leavens M; Hurtubise M; McCredie KB; Bodey GP; Freireich EJ
Cancer; 1985 Aug; 56(3):632-41. PubMed ID: 3891072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]